Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study

Document Details

Document Type
Pub Defense Publication
Publication Date
Oct 01, 2018
Source ID
10.1016/j.jaci.2018.03.018

Entities

People

  • Andreas Wollenberg
  • Grazyna Pulka
  • Jon M. Hanifin
  • Kenji Kabashima
  • Masutaka Furue
  • Miwa Nakano
  • Ryosuke Mihara
  • Ryszard Galus
  • Takafumi Etoh
  • Thomas Ruzicka

Organizations

  • Chugai Pharmaceutical Co.
  • Office of Environmental Management - Project Management